These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32615124)

  • 1. Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Olsen CM; Whiteman DC; MacGregor S
    J Invest Dermatol; 2021 Feb; 141(2):325-333.e6. PubMed ID: 32615124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Hopkins P; Chambers D; Campbell S; Isbel NM; Soyer HP; Olsen CM; Ellis JJ; Whiteman DC; Green AC; MacGregor S
    J Invest Dermatol; 2021 Dec; 141(12):2866-2875.e2. PubMed ID: 34089721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
    Roberts MR; Asgari MM; Toland AE
    Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
    Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
    Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort.
    Stapleton CP; Birdwell KA; McKnight AJ; Maxwell AP; Mark PB; Sanders ML; Chapman FA; van Setten J; Phelan PJ; Kennedy C; Jardine A; Traynor JP; Keating B; Conlon PJ; Cavalleri GL
    Am J Transplant; 2019 Mar; 19(3):801-810. PubMed ID: 30085400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
    Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
    Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
    Krynitz B; Olsson H; Lundh Rozell B; Lindelöf B; Edgren G; Smedby KE
    Br J Dermatol; 2016 Jan; 174(1):95-103. PubMed ID: 26333521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
    Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
    Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.
    Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
    Tee LY; Sultana R; Tam SYC; Oh CC
    J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
    Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
    JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
    Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Patients on Chronic Dialysis: A Cancer Registry-based Study in Taiwan.
    Tang CH; Sue YM; Hsieh WT; Wang YH; Wang CC
    Acta Derm Venereol; 2019 Dec; 99(13):1275-1281. PubMed ID: 31631228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
    Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
    Schauder DM; Kim J; Nijhawan RI
    JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
    Ng JC; Cumming S; Leung V; Chong AH
    Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.